Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
101.36
-0.63 (-0.62%)
At close: Dec 5, 2025, 4:00 PM EST
101.31
-0.05 (-0.05%)
After-hours: Dec 5, 2025, 7:46 PM EST
Medtronic Market Cap
Medtronic has a market cap or net worth of $129.94 billion as of December 5, 2025. Its market cap has increased by 15.68% in one year.
Market Cap
129.94B
Enterprise Value
150.68B
1-Year Change
15.68%
Ranking
Category
Stock Price
$101.36
Market Cap Chart
Since December 1, 1998, Medtronic's market cap has increased from $33.29B to $129.94B, an increase of 290.39%. That is a compound annual growth rate of 5.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 130.75B | 27.65% |
| Dec 31, 2024 | 102.43B | -6.49% |
| Dec 29, 2023 | 109.54B | 5.95% |
| Dec 30, 2022 | 103.38B | -25.68% |
| Dec 31, 2021 | 139.09B | -11.78% |
| Dec 31, 2020 | 157.67B | 3.69% |
| Dec 31, 2019 | 152.07B | 24.48% |
| Dec 31, 2018 | 122.16B | 11.77% |
| Dec 29, 2017 | 109.30B | 11.75% |
| Dec 30, 2016 | 97.80B | -9.58% |
| Dec 31, 2015 | 108.16B | 52.20% |
| Dec 31, 2014 | 71.07B | 24.04% |
| Dec 31, 2013 | 57.30B | 38.11% |
| Dec 31, 2012 | 41.49B | 2.77% |
| Dec 30, 2011 | 40.37B | 1.39% |
| Dec 31, 2010 | 39.82B | -18.05% |
| Dec 31, 2009 | 48.58B | 38.28% |
| Dec 31, 2008 | 35.13B | -38.18% |
| Dec 31, 2007 | 56.84B | -7.73% |
| Dec 29, 2006 | 61.60B | -11.54% |
| Dec 30, 2005 | 69.64B | 15.99% |
| Dec 31, 2004 | 60.04B | 1.90% |
| Dec 31, 2003 | 58.92B | 5.90% |
| Dec 31, 2002 | 55.64B | -10.26% |
| Dec 31, 2001 | 62.00B | -14.54% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |